IRIS - Res&Arch Institutional Research Information System - Research & Archive

EUSEBI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.822
EU - Europa 2.242
AS - Asia 983
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.820
IT - Italia 886
IE - Irlanda 552
SG - Singapore 410
HK - Hong Kong 213
UA - Ucraina 187
CN - Cina 173
VN - Vietnam 122
FR - Francia 102
DE - Germania 88
SE - Svezia 87
FI - Finlandia 83
RU - Federazione Russa 77
RO - Romania 39
GB - Regno Unito 38
TR - Turchia 21
CH - Svizzera 19
CZ - Repubblica Ceca 19
KR - Corea 19
BE - Belgio 15
NL - Olanda 15
AT - Austria 10
PL - Polonia 10
UZ - Uzbekistan 8
JP - Giappone 7
GR - Grecia 6
IN - India 5
LT - Lituania 3
AR - Argentina 2
BG - Bulgaria 2
BR - Brasile 2
CI - Costa d'Avorio 2
CL - Cile 2
ES - Italia 2
EU - Europa 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CA - Canada 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 6.058
Salva come PNG Salva come JPEG
Città #
Chandler 653
Dublin 552
Singapore 340
San Mateo 258
Perugia 233
Hong Kong 211
Boardman 182
Altamura 135
Wilmington 129
Santa Clara 128
Dong Ket 121
Medford 113
Princeton 112
Lawrence 95
Jacksonville 91
Des Moines 79
Beijing 74
Ashburn 70
Andover 69
Ann Arbor 47
Rome 44
Milan 42
Bucharest 30
Los Angeles 26
Helsinki 25
Norwalk 23
Saint Petersburg 23
Salerno 21
Izmir 20
Falls Church 19
Munich 19
Seoul 19
Bologna 16
Brno 15
Brussels 15
Redwood City 14
San Paolo di Civitate 13
Dearborn 12
Houston 12
Modena 12
Dallas 10
Saint Louis 10
Lausanne 9
Moscow 9
Seattle 9
Genoa 8
Woodbridge 8
Fairfield 7
Laion 7
Catania 6
Chicago 6
Parma 6
Prato 6
Shanghai 6
Trento 6
Turin 6
Espoo 5
Florence 5
Frankfurt am Main 5
Naples 5
Napoli 5
New York 5
Redmond 5
Tivoli 5
Amelia 4
Auburn Hills 4
Carlentini 4
Den Haag 4
Genova 4
Lucca 4
Tokyo 4
Udine 4
Verona 4
Borgo Valsugana 3
Cambridge 3
Cosenza 3
El Paso 3
Figline Valdarno 3
Frankfurt Am Main 3
London 3
Mcallen 3
Mumbai 3
Pavia 3
San Nicola Manfredi 3
Saronno 3
Tappahannock 3
Timisoara 3
Washington 3
Abidjan 2
Agordo 2
Arlandastad 2
Atlanta 2
Bagnara Calabra 2
Burano 2
Cagliari 2
Castiglione Del Lago 2
Città Di Castello 2
Faenza 2
Federal 2
Fiesole 2
Totale 4.376
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 439
CSF and blood biomarkers for Parkinson's disease 119
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 110
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 93
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 93
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 83
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 83
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 81
Multilevel Latent Class Models for evaluation of long term care facilities 80
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 78
Stima della non autosufficienza negli anziani in Umbria 76
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 75
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 75
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 74
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 73
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 73
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 72
Association between migraine and headache attributed to stroke: a case-control study. 70
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 70
Occipital arteriovenous malformations andmigraine. 69
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 69
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 67
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 66
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 65
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 65
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 64
Brain arteriovenous malformations and seizures: an Italian study. 61
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 61
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 61
A magnetization transfer study of mild and advanced Parkinson's disease. 61
Le condizioni di salute della popolazione anziana 60
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 59
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 59
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 59
Distorsione dell'immagine corporea nei DCA nei maschi 58
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 58
Underrecognition and undertreatment of dementia in Italian nursing homes. 58
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 57
Lysosomal enzyme activities in human brain 57
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 57
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 56
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 56
Dural arteriovenous fistulas and headache features: an observational study 56
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 56
Health technology disinvestment worldwide: Overview of programs and possible determinants 55
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 55
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 54
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 54
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 53
Stima della non autosufficienza negli anziani in Umbria 52
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 52
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 52
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 52
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 52
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 52
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 51
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 51
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 51
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 50
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 49
Early management of patients with medication-overuse headache: results from a multicentre clinical study 49
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 49
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 49
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 49
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 48
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 48
Latent variable modeling of disability in people aged 65 or more 48
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 48
Le condizioni di salute della popolazione anziana in Umbria 47
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 47
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 47
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 47
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 47
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 47
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 45
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 45
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 45
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 44
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 44
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 44
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 43
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 43
Parkinson's and Lewy body dementia CSF biomarkers 43
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 42
Multilevel Latent Class Models for evaluation of long term care facilities 41
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 41
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 41
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 40
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 40
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 40
Stima della non autosufficienza in Umbria. Anno 2007 e proiezioni al 2015 e 2020 39
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 39
null 39
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 38
Immunological profile of silent brain infarction and lacunar stroke. 38
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 38
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 37
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 37
Obsessive-compulsive disorder and migraine with medication-overuse headache. 37
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 36
Totale 5.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020302 0 0 0 0 0 16 42 27 47 67 40 63
2020/2021715 11 29 17 53 256 18 36 43 66 17 31 138
2021/20221.066 10 189 10 26 39 15 17 279 42 74 197 168
2022/20232.015 123 393 27 174 132 246 6 94 716 5 59 40
2023/2024887 40 82 39 28 18 21 197 38 42 42 151 189
2024/2025764 49 143 87 133 212 140 0 0 0 0 0 0
Totale 6.391